My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Deciphering cellular states of innate tumor drug responses.

    Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S.

    Genome Biol. 2006;7(3):R19. Epub 2006 Mar 15.PMID: 16542501 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

    Petty RD, Samuel LM, Murray GI, MacDonald G, O'Kelly T, Loudon M, Binnie N, Aly E, McKinlay A, Wang W, Gilbert F, Semple S, Collie-Duguid ES.

    BMC Cancer. 2009 Dec 11;9:434.PMID: 20003335 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical determinants of response to irinotecan-based therapy derived from cell line models.

    Allen WL, Coyle VM, Jithesh PV, Proutski I, Stevenson L, Fenning C, Longley DB, Wilson RH, Gordon M, Lenz HJ, Johnston PG.

    Clin Cancer Res. 2008 Oct 15;14(20):6647-55.PMID: 18927307 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Molecular signature for lymphatic metastasis in colorectal carcinomas.

    Croner RS, Förtsch T, Brückl WM, Rödel F, Rödel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, Klein-Hitpass L, Stürzl M, Hohenberger W, Lausen B.

    Ann Surg. 2008 May;247(5):803-10.PMID: 18438117 [PubMed - indexed for MEDLINE]Related articles

    6.

    Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

    Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H.

    Int J Cancer. 2006 Apr 1;118(7):1699-712.PMID: 16217747 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

    Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG.

    Cancer Res. 2006 Mar 1;66(5):2765-77.PMID: 16510598 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.PMID: 16673249 [PubMed - indexed for MEDLINE]Related articles

    9.

    Significant overexpression of Hsp110 gene during colorectal cancer progression.

    Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R.

    Oncol Rep. 2009 May;21(5):1235-41.PMID: 19360299 [PubMed - indexed for MEDLINE]Related articles

    10.

    Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.

    Jung JJ, Jeung HC, Lee JO, Kim TS, Chung HC, Rha SY.

    Oncol Rep. 2007 Sep;18(3):593-9.PMID: 17671706 [PubMed - indexed for MEDLINE]Related articles

    11.

    Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

    Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S.

    Oncol Res. 2005;16(3):143-56.PMID: 16925115 [PubMed - indexed for MEDLINE]Related articles

    12.

    Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

    Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD.

    Lancet Oncol. 2007 Dec;8(12):1071-8. Epub 2007 Nov 19.PMID: 18024211 [PubMed - indexed for MEDLINE]Related articles

    13.

    Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

    Quintieri L, Fantin M, Vizler C.

    Adv Exp Med Biol. 2007;593:95-104. Review.PMID: 17265720 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models.

    Bracker TU, Sommer A, Fichtner I, Faus H, Haendler B, Hess-Stumpp H.

    Int J Oncol. 2009 Oct;35(4):909-20.PMID: 19724929 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Functional mRNA expression analysis and classification of colonic biopsy samples using overall cDNA microarray technique]

    Galamb O, Sipos F, Dinya E, Spisák S, Somorácz A, Molnár B, Tulassay Z.

    Orv Hetil. 2008 Feb 3;149(5):219-32. Hungarian. PMID: 18218589 [PubMed - indexed for MEDLINE]Related articles

    16.

    Gene profiling of colonic serrated adenomas by using oligonucleotide microarray.

    Kim K, Park U, Wang J, Lee J, Park S, Kim S, Choi D, Kim C, Park J.

    Int J Colorectal Dis. 2008 Jun;23(6):569-80. Epub 2008 Feb 28.PMID: 18305945 [PubMed - indexed for MEDLINE]Related articles

    17.

    Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis.

    Oku Y, Shimoji T, Takifuji K, Hotta T, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, Nasu T, Tamura K, Matsuura M, Miyata S, Kato Y, Yamaue H, Miki Y.

    Clin Cancer Res. 2008 Nov 15;14(22):7215-22.PMID: 19010838 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.

    Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.

    J Natl Cancer Inst. 2007 Jul 18;99(14):1107-19. Epub 2007 Jul 10.PMID: 17623797 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.

    Fiebig HH, Schüler J, Bausch N, Hofmann M, Metz T, Korrat A.

    Cancer Genomics Proteomics. 2007 May-Jun;4(3):197-209.PMID: 17878523 [PubMed - indexed for MEDLINE]Related articles

    20.

    Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

    Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT.

    BMC Cancer. 2009 Mar 5;9:77.PMID: 19265549 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk